Treatment of melanoma by passive humoral immunotherapy using antibody drug synergism (Q66695260)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

title

Treatment of melanoma by passive humoral immunotherapy using antibody drug synergism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

1 reference

K D Everall

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

P Dowd

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

D A Davies

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

G J O'Neill

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

G F Rowland

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

language of work or name

English

0 references

publication date

1 May 1977

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

issue

8021

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

page(s)

1105-1106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

Comparison of the combination of 1, 3-bis(2-chloroethyl)-l-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-l-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma

22 August 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992359-5

7 January 2021

Antibody as carrier of chlorambucil

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992359-5

7 January 2021

Suppression of tumour growth in mice by a drug–antibody conjugate using a novel approach to linkage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992359-5

7 January 2021

Immunochemotherapy of Cancer with Chlorambucil-carrying Antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992359-5

7 January 2021

Immunochemotherapy of human malignant melanoma with chlorambucil-carrying antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992359-5

7 January 2021

Protection of mice against syngeneic lymphomata: II. Collaboration between drugs and antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992359-5

7 January 2021

Protection of mice against syngeneic lymphomata: I. Use of antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992359-5

7 January 2021

Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2877%2992359-5

7 January 2021

10.1016/S0140-6736(77)92359-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:68204%20AND%20SRC:MED&resulttype=core&format=json

22 August 2019

1 reference